Literature DB >> 30768828

β-Selective C-Glycosylation and its Application in the Synthesis of Scleropentaside A.

G Jacob Boehlich1, Nina Schützenmeister1.   

Abstract

C-Glycosides are carbohydrates that bear a C-C bond to an aglycon at the anomeric center. Due to their high stability towards chemical and enzymatic hydrolysis, these compounds are widely used as carbohydrate mimics in drug development. Herein, we report a general and exclusively β-selective method for the synthesis of a naturally abundant acyl-C-glycosidic structural motif first found in the scleropentaside natural product family. A Corey-Seebach umpolung reaction as the key step in the synthesis of scleropentaside A and analogues enables the β-selective construction of the anomeric C-C bond starting from unprotected carbohydrates in only four steps. The one-pot approach is highly atom-efficient and avoids the use of toxic heavy metals.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  C-glycosides; carbohydrates; natural products; scleropentasides; umpolung

Year:  2019        PMID: 30768828     DOI: 10.1002/anie.201900995

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  4 in total

1.  Versatile Glycosyl Sulfonates in β-Selective C-Glycosylation.

Authors:  Jesse Ling; Clay S Bennett
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-03       Impact factor: 15.336

2.  Diastereoselective Synthesis of Aryl C-Glycosides from Glycosyl Esters via C-O Bond Homolysis.

Authors:  Yongliang Wei; Benjamin Ben-Zvi; Tianning Diao
Journal:  Angew Chem Int Ed Engl       Date:  2021-03-10       Impact factor: 15.336

3.  Synthesis of C-acyl furanosides via the cross-coupling of glycosyl esters with carboxylic acids.

Authors:  Yongliang Wei; Jenny Lam; Tianning Diao
Journal:  Chem Sci       Date:  2021-07-23       Impact factor: 9.825

Review 4.  Glycosylation and its research progress in endometrial cancer.

Authors:  Congli Pu; Kai Xu; Yingchao Zhao
Journal:  Clin Transl Oncol       Date:  2022-06-25       Impact factor: 3.340

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.